Compare Corteva, Inc. with Similar Stocks
Stock DNA
Chemicals & Petrochemicals
USD 53,156 Million (Large Cap)
43.00
NA
94.80%
-0.08
5.10%
2.20
Revenue and Profits:
Net Sales:
4,905 Million
(Quarterly Results - Mar 2026)
Net Profit:
725 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.91%
0%
8.91%
6 Months
23.26%
0%
23.26%
1 Year
26.55%
0%
26.55%
2 Years
37.47%
0%
37.47%
3 Years
35.74%
0%
35.74%
4 Years
41.86%
0%
41.86%
5 Years
61.83%
0%
61.83%
Corteva, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.12%
EBIT Growth (5y)
23.66%
EBIT to Interest (avg)
21.66
Debt to EBITDA (avg)
0.43
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0.59
Tax Ratio
26.82%
Dividend Payout Ratio
43.60%
Pledged Shares
0
Institutional Holding
89.36%
ROCE (avg)
6.69%
ROE (avg)
5.88%
Valuation key factors
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
2.20
EV to EBIT
21.00
EV to EBITDA
14.05
EV to Capital Employed
2.31
EV to Sales
2.94
PEG Ratio
7.64
Dividend Yield
94.80%
ROCE (Latest)
11.01%
ROE (Latest)
5.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bullish
Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 164 Schemes (43.11%)
Foreign Institutions
Held by 450 Foreign Institutions (18.14%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
4,905.00
4,417.00
11.05%
Operating Profit (PBDIT) excl Other Income
1,458.00
1,094.00
33.27%
Interest
36.00
36.00
Exceptional Items
-299.00
14.00
-2,235.71%
Consolidate Net Profit
725.00
667.00
8.70%
Operating Profit Margin (Excl OI)
236.70%
180.70%
5.60%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.05% vs -1.67% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 8.70% vs 77.39% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
17,401.00
16,908.00
2.92%
Operating Profit (PBDIT) excl Other Income
3,991.00
3,294.00
21.16%
Interest
180.00
233.00
-22.75%
Exceptional Items
-211.00
-301.00
29.90%
Consolidate Net Profit
1,204.00
863.00
39.51%
Operating Profit Margin (Excl OI)
160.20%
122.20%
3.80%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.92% vs -1.85% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 39.51% vs -8.29% in Dec 2024
About Corteva, Inc. 
Corteva, Inc.
Chemicals & Petrochemicals
Corteva, Inc. is a provider of agricultural products. The Company’s seed platform develops and supplies germplasm. Its crop protection platform supplies products to protect crop yields against weeds, insects and disease. It operates through two segments: seed and crop protection. Its seed segment provides solutions in various crops, including corn, soybean, sunflowers and wheat, and complementary crops such as alfalfa, canola, cotton, rice and sorghum, as well as silage inoculants. Its crop protection segment is focused on developing and supplying crop protection products and services. It offers a range of crop protection products that service field crops, such as wheat, corn, soybean, sunflower, canola/oilseed rape and rice as well as specialty crops such as fruit, nut, vine, sugarcane, coffee and vegetables.
Company Coordinates 
Company Details
974 Centre Rd Bldg 735 , WILMINGTON DE : 19805-1269
Registrar Details






